47 research outputs found
PCN17 SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY OF IMIQUIMOD 5% CREAM FOR THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA
Get PDFPDB5 COMPARISON OF CLINICAL EFFECTIVENESS AND SAFETY OF GLULISINE VERSUS INSULIN LISPRO, ASPART AND REGULAR HUMAN INSULIN IN PATIENTS WITH TYPE I AND 2 DIABETES
Get PDFPCN13 COST-EFFECTIVENESS ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE ADJUVANT THERAPY OF EARLY AND LOCALLY ADVANCED BREAST CANCER IN POLAND
Get PDFPCN99 COST-EFFECTIVENESS ANALYSIS OF IMIQUIMOD VERSUS NO TREATMENT IN PATIENTS WITH SUPERFICIAL BASAL CELL CARCINOMA AND CONTRAINDICATION TO SURGICAL INTERVENTION/CRYOTHERAPY
Get PDFPDB16 THE COST-UTILITY AND BUDGET IMPACT ANALYSIS OF SITAGLIPTIN (JANUVIA®) IN TYPE 2 DIABETES IN POLAND
Get PDF
PMH40 COST-UTILITY ANALYSIS (CUA) OF SERTINDOLE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND IN GENERAL POPULATION OF SCHIZOPHRENIC PATIENTS AND POPULATION OF PATIENTS INTOLERANT TO AT LEAST ONE OTHER ANTIPSYCHOTIC AGENT: A FIVE-YEAR MARKOV MODEL
No full textPMH13 COST-UTILITY AND BUDGET IMPACT OF SERTINDOLE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND
Get PDFPSS4 SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY OF IMIQUIMOD 5% CREAM FOR THE TREATMENT OF ACTINIC KERATOSES
Get PDFPSS4 SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY OF IMIQUIMOD 5% CREAM FOR THE TREATMENT OF ACTINIC KERATOSES
No full text
